A global leader in providing technology enabled business solutions and services

A global leader in providing technology enabled business solutions and services.

Services
Partners
About Us
Careers
Contact Us

Register | Login

Welcome, | Log Out

Services
Partners
About Us
Careers
Contact Us

Home /
DVC LLC /
DVC Press Releases

Back
More Links

DVC LLC

DynPort Home
About DynPort
Services
Success Stories
Partners
Newsroom
DynPort Careers
Events
Knowledge Library
Bugs and Drugs Blog

DVC Press Releases

DynPort Vaccine Company LLC (DVC) is a wholly owned subsidiary of CSC. Recent press releases issued by CSC about DVC are included on this page. Visit the CSC newsroom to view all CSC press releases. We don't issue many press releases, so you might want to check out our news articles and partners newsletter for more news and information.

|<

<

Page of

>

>|

Sort Title

A-Z Sort Ascending
Z-A Sort Descending
Filters

Sort Client

A-Z Sort Ascending
Z-A Sort Descending
Filters

Sort Date

Sort Reverse Chronologically
Sort Chronologically

|<

<

Page of

>

>|

Sort Title

A-Z Sort Ascending
Z-A Sort Descending
Filters

Sort Client

A-Z Sort Ascending
Z-A Sort Descending
Filters

Sort Date

Sort Reverse Chronologically
Sort Chronologically

CSC's DynPort Vaccine Company Releases Results for Phase 2 Botulinum Vaccine Clinical Trial CSC announced today that DynPort has completed a Phase 2 clinical trial for its recombinant botulinum vaccine candidate, rBV A/B.
CSCs DynPort Vaccine Company Completes Vaccinations and Study Visits in Phase 2 Botulinum Vaccine Clinical Trial CSC announced today that DVC completed vaccination and follow-up of all volunteers in a Phase 2 clinical trial for its botulinum vaccine.
CSC's DynPort Vaccine Company Initiates Phase 2b Clinical Trial of Plague Vaccine for U.S. Department of Defense CSC announced today that DVC has initiated a Phase 2b clinical trial for its Yersinia pestis Plague Recombinant Vaccine (rF1V) candidate.
CSC’s Dynport Vaccine Company is Awarded UK Ministry of Defence Contract for Plague Vaccine Work CSC announced today that the United Kingdom Ministry of Defence (UKMOD) awarded DynPort Vaccine Company LLC (DVC), a CSC company, a contract to scope the requirements for achieving licensure of the plague vaccine in the European Union.

CSC Recommendations

LOG OUT
EDIT PROFILE

Recommended Reading

Coca-Cola Supply Chain Management Success Story

Coca-Cola has dominated the beverage market for over a century, yet still values...

Coordinated Care: Making Healthcare More Effective and Efficient

Healthcare organizations around the world face formidable challenges as they look to...

The Future of 3D Printing Services and Manufacturing

CSC explores the future of 3D printing and manufacturing, as 3D printing manufacturing...

Our Strategy: Moving Forward

This past year, CSC launched a full-scale turnaround to elevate our business performance...

ABOUT CSC
SUCCESS STORIES
CAREERS
GLOBAL ALLIANCES
NEWSROOM
INVESTOR RELATIONS

CSC WIRE

CSC Agrees to Sell Base Operations, Aviation and Range Services Unit
CSC Board Declares Quarterly Cash Dividend
CSC Reports Continuing Operating Improvement and Strong Profitability in Fourth Quarter and Fiscal Year 2013

Engage With Us

CSC Town Hall
View On-Demand Events

CSC Communities

Office of Innovation

Meet our Ingenious Minds

Feedback

Follow Us

CSC

Legal |
Privacy |
Site Map
© Computer Sciences Corp